Inmune Bio, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q4 2020 to Q2 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Inmune Bio, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q4 2020 to Q2 2024.
- Inmune Bio, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $2.35M, a 26.1% increase year-over-year.
- Inmune Bio, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $7.37M, a 3.06% increase from 2022.
- Inmune Bio, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $7.15M, a 49.1% increase from 2021.
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)